p16INK4a Translation Suppressed by miR-24
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Expression of the tumor suppressor p16(INK4a) increases during aging and replicative senescence. METHODOLOGY/PRINCIPAL FINDINGS: Here, we report that the microRNA miR-24 suppresses p16 expression in human diploid fibroblasts and cervical carcinoma cells. Increased p16 expression with replicative senescence was associated with decreased levels of miR-24, a microRNA that was predicted to associate with the p16 mRNA coding and 3'-untranslated regions. Ectopic miR-24 overexpression reduced p16 protein but not p16 mRNA levels. Conversely, introduction of antisense (AS)-miR-24 blocked miR-24 expression and markedly enhanced p16 protein levels, p16 translation, and the production of EGFP-p16 reporter bearing the miR-24 target recognition sites. CONCLUSIONS/SIGNIFICANCE: Together, our results suggest that miR-24 represses the initiation and elongation phases of p16 translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Lowering miR-24 increases p16 levels in HeLa cells. (A) Cells were transfected with either a control (Ctrl.) siRNA or antisense (AS) miR-24 (100 nM) and the levels of mRNAs encoding p16, and controls GAPDH (for normalization) and SDHA were calculated by RT-qPCR and represented as the means+SD from 3 independent experiments; the levels of miR-24 and U6 RNA were also measured. (B) Representative Western blot analysis of p16 (and loading control α-Tubulin) levels in each transfection group. p16 signals were measured by densitometry and represented as % p16 levels relative to the control transfection group. (C) The levels of miR-24 were measured by RT-qPCR in each of the fractions (Materials and Methods) and shown as relative miR-24 levels in the AS-miR-24 transfection group relative to the levels in the Ctrl. siRNA transfection group (left) and also as a percentage of the total miR-24 in each of the two transfection groups (right). Note that the abundance of miR-24 was preferentially reduced in fractions 1 and 2 (left), but the remaining miR-24 was found distributed among all of the fractions of the polysome gradient (right). Data are representative from three independent experiments yielding similar results. (D) The levels of p16 and control GAPDH mRNAs on polysome gradients were measured and represented as explained in the legend of Fig. 1C. (E) Nascent translation of p16 or (control) GAPDH was monitored following incubation of cells with L-[35S]methionine and L-[35S]cysteine for 15 min; after immunoprecipitation (IP) using either anti-p16 (left) or anti-GAPDH (right) antibodies along with control IgG, the incorporation of radiolabeled amino acids into newly synthesized p16 and GAPDH polypeptides was visualized after SDS-PAGE and quantified using a PhosphorImager; the % change in p16 nascent translation is shown.](https://figures.cochat.ai/paper-figures/880eb3a1463b4866ba4e9e44241dd770/p16ink4a-translation-suppressed-by-mir-24-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, miR-24 suppresses p16 INK4a in cells (Lal et al., 2008) and disease models, including osteoarthritis (Philipot et al., 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Lal et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Multiple studies have demonstrated that different miRNAs modulate the levels of key senescence effectors such as p53 (Hu et al., 2010; Burns et al., 2011; Xiao et al., 2011), p21WAF1/CIP1 (Borgdorff et al., 2010), p16INK4A (Lal et al., 2008; Overhoff et al., 2014; Philipot et al., 2014), and SIRT1 (Suh, 2018; Baker et al., 2019; Barnes et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lal et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186 · cited 1×
“Transcriptionally, CDC6 was reported to silence the INK4a/ARF locus by heterochromatinization linked to DNA replication [11].”
RetractedThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · cited 1×
“Cellular senescence is triggered by stimuli such as aberrant proliferative signals or damage to DNA or other macromolecules [4, 5].”
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W.-L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,063 · cited 1×
“), based on analysis using the Miranda and RNA22 programs (”
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060 · cited 6×
“The miRNAmediated silencing of gene expression has been linked to the recruitment of target mRNAs to P-bodies; these foci are implicated in mRNA degradation [31], and also in translational repression as they lack translational constituents and contain protein components of RISC (such as Ago1) that interact directly wi…”
InfluentialMicroRNA-Directed Cleavage of HOXB8 mRNA
Yekta, S., Shih, I.-H., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1097434 · Cited by 1,702
A microRNA in a Multiple-Turnover RNAi Enzyme Complex
Hutvágner, G., & Zamore, P. D. (2002) · Science · doi:10.1126/science.1073827 · Cited by 1,674
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Decapping and Decay of Messenger RNA Occur in Cytoplasmic Processing Bodies
Sheth, U., & Parker, R. (2003) · Science · doi:10.1126/science.1082320 · Cited by 1,365 · cited 1×
“The miRNAmediated silencing of gene expression has been linked to the recruitment of target mRNAs to P-bodies; these foci are implicated in mRNA degradation [31], and also in translational repression as they lack translational constituents and contain protein components of RISC (such as Ago1) that interact directly wi…”
Olsen, P. H., & Ambros, V. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9523 · Cited by 1,234 · cited 1×
“elegans miRNA lin-4, which silenced lin-14 and lin-28 mRNAs without changing their polysomal distribution [34,35].”
Cited by
Items 101–200 of 267
High Frequency of p16 Promoter Methylation in NRAS-Mutated Cutaneous Melanoma
Jonsson, A., Tuominen, R., Grafström, E., Hansson, J., & Egyházi, S. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.216 · Cited by 73
“Posttranscriptional micro-RNA-mediated suppression of p16 translation by miR-24 has also been reported (Lal et al., 2008).”
BackgroundDifferential Expression Profiles of microRNAs in NIH3T3 Cells in Response to UVB Irradiation
Guo, L., Huang, Z., Chen, X., Deng, Q., Yan, W., Zhou, M., Ou, C., & Ding, Z. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00482.x · Cited by 66
MicroRNA programs in normal and aberrant stem and progenitor cells
Arnold, C. P., Tan, R., Zhou, B., Yue, S.-B., Schaffert, S., Biggs, J. R., Doyonnas, R., Lo, M.-C., Perry, J. M., Renault, V. M., et al. (2011) · Genome Research · doi:10.1101/gr.111385.110 · Cited by 65
“…shown to regulate the cell cycle: miR-16, miR-19b, miR-20, miR-24, miR-29c, miR-92, miR-106b, miR-195, miR-221, miR-222, let-7b, and let-7c, (Zhang et al. 2007; Lal et al. 2008; Liu et al. 2008b; Medina et al. Genome Research 807 www.genome.org 2008; Mendell 2008; Park et al. 2009; Xu et al. 2009).”
Giglio, S., Cirombella, R., Amodeo, R., Portaro, L., Lavra, L., & Vecchione, A. M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24368 · Cited by 66
Guo, Y., Fu, W., Chen, H., Shang, C., & Zhong, M. (2011) · Oncology Reports · doi:10.3892/or.2011.1571 · Cited by 72
“Most evidence suggested that miR-24 is aberrantly expressed in many kinds of cancers and the erythropoiesis process, which lead to significantly malignancies and cell differentiation alteration (8-11).”
DNA methylation of microRNA genes in multiple myeloma
Wong, K. Y., Huang, X., & Chim, C. S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs212 · Cited by 69
“Furthermore, miR-24 and miR-155 have been shown to target the 3′ UTR of, and hence repress CDKN2A and SOCS1, respectively (106,107).”
BackgroundmiR-124 Inhibits Growth and Invasion of Gastric Cancer by Targeting ROCK1
Cong-bing, H., Li, Q.-L., Hu, J., Zhang, Q., Xie, J., & Deng, L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6543 · Cited by 65
“Thus, it is urgent to study the underling molecular mechanism of GC. MicroRNAs (miRNAs) are single-strand, small noncoding RNAs that play important roles in posttranscriptional repression (Lal et al., 2008).”
BackgroundLouis‐Brennetot, C., Coindre, J., Ferreira, C., Pérot, G., Terrier, P., & Aurias, A. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20909 · Cited by 65
“This observation suggests that mechanisms other than deletion or methylation could explain the downregulation of the gene, such as silencing by miRNA, as previously described (Guled et al., 2009; Lal et al., 2008).”
Result5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells
Shah, M., Pan, X., Fix, L. N., Farwell, M. A., & Zhang, B. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22517 · Cited by 67
“…targets PTEN (phosphatase and tensin homolog) (Meng et al., 2007), TPM1 (tropomyosin1) (Zhu et al., 2007), and PDCD4 (programmed cell death protein 4) (Asangani et al., 2008). p16 and p57 have been found to be modulated by miRNAs miR-24 (Lal et al., 2008) and miR25 (Kim et al., 2009), respectively.”
BackgroundThe impact of microRNAs and alternative splicing in pharmacogenomics
Passetti, F., Ferreira, C. G., & Costa, F. F. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.14 · Cited by 64
Evangelou, K., Bartkova, J., Kotsinas, A., Pateras, I. S., Liontos, M., Velimezi, G., Kosar, M., Liloglou, T., Trougakos, I. P., Dyrskjot, L., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.76 · Cited by 59
“Most of our knowledge regarding INK4/ARF expression concerns p16 regulation at transcriptional(17) and post-translational level.(51,52) Its induction is often associated with mitogen-activated protein kinase activation.”
BackgroundVascular Ageing: Mechanisms, Risk Factors, and Treatment Strategies
Ya, J., & Bayraktutan, U. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411538 · Cited by 57
MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells
Potter, M. L., Hill, W., Isales, C. M., Hamrick, M. W., & Fulzele, S. (2020) · Bone · doi:10.1016/j.bone.2020.115679 · Cited by 63
Yang, I., Tsai, H., Huang, C., Lu, C., Miao, Z., Chang, S.-F., Juo, S. H., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7719 · Cited by 60
“Previous studies indicate that miRs in the plasma microvesicles might regulate the progression of cell-cycle proteins [51, 52].”
BackgroundThe nuclear envelope can control gene expression and cell cycle progression via miRNA regulation
Malhas, A. N., Saunders, N. J. S. G., & Vaux, D. J. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10511 · Cited by 59
Impact of MicroRNAs in the Cellular Response to Hypoxia
Bertero, T., Rezzonico, R., Pottier, N., & Mari, B. P. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.006 · Cited by 62
Martin, E. C., Elliott, S., Rhodes, L. V., Antoon, J. W., Fewell, C., Zhu, Y., Driver, J. L., Jodari‐Karimi, M., Taylor, C. W., Flemington, E. K., et al. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.21946 · Cited by 54
Salvi, A., Abeni, E., Portolani, N., Barlati, S., & Petro, G. D. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1716 · Cited by 56
“In another study miR-24 acted as an oncomiR negatively regulating p16 in cervical carcinoma cells and the pro-apoptotic FAF1 protein in prostate, gastric and HeLa cancer cells (36,37).”
BackgroundRadpour, R., Barekati, Z., Kohler, C., Schumacher, M. M., Grussenmeyer, T., Jenoe, P., Hartmann, N., Moes, S., Letzkus, M., Bitzer, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027355 · Cited by 54
Significance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 68
“dependent kinases CDK4 and CDK6 to maintain pRb in a hypophosphorylated state (82).”
BackgroundMicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma
Zheng, X., Li, J., Chen, P., Zhao, J., Chi, J., Meng, X., Yun, X., Li, D., Yu, Y., Gao, M., et al. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.08.002 · Cited by 51
“In addition, upregulation of miR-24 has also been observed in gastric and cervical cancers [23,24].”
BackgroundMicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4
Deng, Y., Deng, Z. H., Hu, H., Wu, X. L., Gao, H., Tang, S. H., & Tang, H. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.10.010 · Cited by 51
Loveday, E.-K., Diederich, S., Pasick, J. M. M., & Jean, F. (2014) · Journal of General Virology · doi:10.1099/vir.0.068585-0 · Cited by 50
To, K.-H., Pajovic, S., Gallie, B. L., & Thériault, B. L. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-69 · Cited by 52
“For example, expression of miR-125b and miR-24 is similar in retinoblastomas [28], and miR125b has been shown to regulate the 3’ untranslated region of p16 and ARF mRNA [20].”
BackgroundMicroRNAs as a novel cellular senescence regulator
Liu, F., Wen, T., & Liu, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.001 · Cited by 56
From cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47
“During the last few years, several studies have then identified differentially transcribed miRNAs during cellular senescence in various cell types and different senescence inducing conditions including fibroblasts [57-63], keratinocytes [64,65], endothelial cells [51,66,67], renal cells, [51,68], T-cells [51], human m…”
BackgroundVannini, I., Wise, P. M., Challagundla, K. B., Plousiou, M., Raffini, M., Bandini, E., Fanini, F., Paliaga, G., Crawford, M., Ferracin, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01562-9 · Cited by 48
MicroRNA as a new player in the cell cycle
Chen, D., Farwell, M. A., & Zhang, B. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22234 · Cited by 53
“Expression of p16 is also suppressed in human diploid fibroblasts and cervical carcinoma cells by miR-24 without changing its mRNA level (Lal et al., 2008).”
BackgroundAlmontashiri, N. A. M., Fan, M., Cheng, B. L. M., Chen, H., Roberts, R., & Stewart, A. F. R. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1020 · Cited by 49
Barnhill, L. M., Williams, R. T., Cohen, O., Kim, Y.-J., Batova, A., Mielke, J. A., Messer, K. S., Pu, M., Bao, L., Yu, A. L.-T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3447 · Cited by 46
The impact of noncoding RNA on the biochemical and molecular mechanisms of aging
Bates, D. J., Liang, R., Li, N., & Wang, E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.028 · Cited by 50
miR-27 regulates mitochondrial networks by directly targeting the mitochondrial fission factor
Tak, H., Kim, J., Jayabalan, A. K., Lee, H., Kang, H., Cho, D., Ohn, T., Nam, S. W., Kim, W., & Lee, E. K. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.73 · Cited by 44
Khee, S. G. S., Yusof, Y. A. M., & Makpol, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/725929 · Cited by 41
Wu, J., Zhang, Y.-C., Suo, W.-H., Liu, X.-B., Shen, W.-W., Tian, H., & Fu, G. (2010) · Oncogene · doi:10.1038/onc.2009.481 · Cited by 41
MiR-24 Promotes the Survival of Hematopoietic Cells
Nguyen, T. A., Rich, A., & Dahl, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055406 · Cited by 40
“Reported targets of miR-24 include pro-apoptotic proteins (FAF-1, Caspase 9, Bim and Apaf-1)[8,9,10,11,12,13,14] with miR-24 expression associated with survival.”
BackgroundThe Role of MicroRNAs in Kidney Disease
Mukhadi, S., Hull, R., Mbita, Z., & Dlamini, Z. (2015) · Non-Coding RNA · doi:10.3390/ncrna1030192 · Cited by 48
“Target sites for miRNA binding are commonly found in the 3'-untranslated region (UTR) but can be found in the 5'-UTR or the coding region of the target mRNAs as well [11–13].”
BackgroundCanine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
Kabir, F. M. L., Alvarez, C. E., & Bird, R. (2015) · Veterinary Sciences · doi:10.3390/vetsci3010001 · Cited by 47
“of cell cycle in many cancers [141,142].”
Feng, J., Kim, S., Liu, W., Kim, J. W., Zhang, Z., Zhu, Y., Berens, M., Sun, J., & Xu, J. (2012) · Cancer · doi:10.1002/cncr.26250 · Cited by 38
MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas
Beylerli, O., Beeraka, N. M., Фанилевич, Г. И., Павлов, В. Н., Yang, G., Liang, Y., & Aliev, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197287 · Cited by 38
“miR-24 is reported to impair p16INK4a expression in cervical cancer cells [14].”
miR-24 Regulates Intrinsic Apoptosis Pathway in Mouse Cardiomyocytes
Wang, L., & Li, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085389 · Cited by 35
“miR-24 is one of the microRNAs that functions in multiple biological processes, including erythroid differentiation, DNA-repair process, cell cycle regulation and programmed cell death [29,30,31,32,33,34].”
BackgroundMicromanaging aging with miRNAs: new messages from the nuclear envelope
Ugalde, A. P., Español, Y., & López-Otín, C. (2011) · Nucleus · doi:10.4161/nucl.2.6.17986 · Cited by 34
“murine fibroblasts activates p19ARF and p16INKa and triggers cellular senescence,(49) whereas miR-24 decrease in senescent human fibroblasts is in part responsible for p16INKa up-modulation.(50) Similarly, the five members of the miR-106b family, including the aforementioned miR-20a, are downregulated in stressinduced…”
BackgroundRole of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
Unraveling the Global microRNAome Responses to Ionizing Radiation in Human Embryonic Stem Cells
Sokolov, M. V., Panyutin, I. V., & Neumann, R. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031028 · Cited by 37
“Mir-24 is implicated in halting cell cycle progression and inhibition of apoptosis [71], and impairment of DDR and senescence program execution [72,73].”
BackgroundCoding region: The neglected post-transcriptional code
Lee, E. K., & Gorospe, M. (2011) · RNA Biology · doi:10.4161/rna.8.1.13863 · Cited by 43
Self-citationMYCNOS functions as an antisense RNA regulating MYCN
Vadie, N., Saayman, S. M., Lenox, A., Ackley, A., Clemson, M., Burdach, J., Hart, J. R., Vogt, P. K., & Morris, K. V. (2015) · RNA Biology · doi:10.1080/15476286.2015.1063773 · Cited by 43
“This mechanism is inhibited by the action of 50 aza cytidine (50Aza-C) and trichostatin A (TSA).(9-11,14) We find that treatment of Lan6 cells with 50Aza-C and TSA results in a significant increase in the level of MYCN Figure 1.”
BackgroundWeilner, S., Grillari‐Voglauer, R., Redl, H. R., Grillari, J., & Nau, T. (2014) · Acta Orthopaedica · doi:10.3109/17453674.2014.957079 · Cited by 37
“However, whether the observed downregulation of miR-34a in osteosarcoma directly impairs bone formation, or whether the enhanced formation is due to a prevention of senescence, which would otherwise inhibit tumor formation, is not clear (He et al. 2009).”
BackgroundThe emerging role of miRNAs in biological aging and age-related diseases
Turko, R., Hajja, A., Magableh, A. M., Omer, M. H., Shafqat, A., Khan, M. I., & Yaqinuddin, A. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.05.002 · Cited by 43
“Hence, studies have attempted to use liposomal microRNA-195 as a possible therapy for AD: intravenous nanoliposomes encapsulating [59,60] (PEI)/miR-195 complex (DPMT@PEI/miR-195) can alleviate cognitive decline in APP/PS1 mice — an animal model of AD) [141].”
Quann, K., Yi, J., & Rigoutsos, I. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00242 · Cited by 37
“…of these non3′UTR targets as well as many 3′UTR targets happened to contain various combinations of bulges and G:U wobbles in the seed region, instead of the Watson–Crick base pairs of the standard model (Ha et al., 1996; Lal et al., 2008; Tay et al., 2008; Chi et al., 2012; Loeb et al., 2012).”
BackgroundLong Non-Coding RNAs Embedded in the Rb and p53 Pathways
Subramanian, M., Jones, M. F., & Lal, A. (2013) · Cancers · doi:10.3390/cancers5041655 · Cited by 38
“CDK4 or CDK6 mRNAs are also targeted by other miRNAs, including miR-24, miR-34a, miR-124, miR-125b, miR-129, miR-137, miR-195, miR-449 and the let-7 family members [18–22].”
BackgroundSelf-citationThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
Diab, M., Muqbil, I., Mohammad, R. M., Azmi, A. S., & Philip, P. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5060059 · Cited by 34
“Studies have shown the inhibitory role of miR-10b and -24 on the expression of p16 in malignancies other than pancreatic cancer [39,40].”
BackgroundMelatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs
Fathalizadeh, A., Rahnemayan, S., Rajabi, H., Vahed, N., Kashani, H. R. K., Rezabakhsh, A., & Sanaie, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105839 · Cited by 34
Endothelial Cell Aging: How miRNAs Contribute?
Yamakuchi, M., & Hashiguchi, T. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7070170 · Cited by 32
“miR-24 was involved in the process of senescence through targeting p16 [121], however, the role of miR-27 has not been elucidated yet.”
Gene bi-targeting by viral and human miRNAs
Veksler‐Lublinsky, I., Shemer‐Avni, Y., Kedem, K., & Ziv-Ukelson, M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-249 · Cited by 32
“Furthermore, human miRNA miR-24, which presents in this module, has been demonstrated to promote cell growth through repression of this gene [73].”
BackgroundRegulation of TRIB3 mRNA and Protein in Breast Cancer
Wennemers, M., Bussink, J., van den Beucken, T., Sweep, F. C. G. J., & Span, P. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049439 · Cited by 36
“Furthermore it plays a role in cell cycle regulation [20,21] and is frequently de-regulated in tumor cells [21].”
BackgroundRegulation of cellular senescence by microRNAs
Ma, X., Zheng, Q., Zhao, G., Yuan, W., & Liu, W. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111264 · Cited by 30
miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes
McKenna, D. J., Patel, D., & McCance, D. J. (2013) · Virology · doi:10.1016/j.virol.2013.10.014 · Cited by 30
“As a control, we quantified levels of p16, a known target of miR-24 (Lal et al., 2008).”
MethodLiang, L.-H., & He, X. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.103 · Cited by 35
Rigoutsos, I., Londin, E. R., & Kirino, Y. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.05.014 · Cited by 27
Fasoulakis, Z. N., Daskalakis, G. J., Diakosavvas, M., Papapanagiotou, I., Theodora, M. K., Bourazan, A., Alatzidou, D., Pagkalos, A., & Kontomanolis, E. N. (2019) · MicroRNA · doi:10.2174/2211536608666190919161849 · Cited by 43
Paradoxical microRNAs: Individual gene repressors, global translation enhancers
Srikantan, S., Marasa, B. S., Becker, K. G., Gorospe, M., & Abdelmohsen, K. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14825 · Cited by 30
Self-citationKoturbash, I., Beland, F. A., & Pogribny, I. P. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.673587 · Cited by 35
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
Flavonoid display ability to target microRNAs in cancer pathogenesis
Singh, S., Raza, W., Parveen, S., Meena, A., & Luqman, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114409 · Cited by 32
Interaction Map and Selection of microRNA Targets in Parkinson′s Disease‐Related Genes
Shinde Santosh, P., Arora, N., Sarma, P. N., Pal‐Bhadra, M., & Bhadra, U. (2009) · BioMed Research International · doi:10.1155/2009/363145 · Cited by 33
“Copyright © 2009 Shinde Santosh P. et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodXu, X., Tsang, S. W., Guan, Y.-F., Liu, K., Pan, W.-H., Lam, C. S., Lee, K. M., Xia, Y.-X., Xie, W.-J., Wong, W., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01742 · Cited by 27
Epigenetic regulation of prostate cancer
Wang, R., & Liu, X. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.018 · Cited by 30
Platelet miRNAs and cardiovascular diseases
Fuentes, E., Palomo, I. F., & Alarcón, M. A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.016 · Cited by 31
Liu, C., Li, D., Jiang, J., Hu, J., Zhang, W., Chen, Y., Cui, X., Yan, Q., Zou, H., Zhang, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094924 · Cited by 27
“ALK4, MAPK14, and CDKN2A have been shown to be the target genes of multiple miRNAs, including miRNA-24 [55,56,57].”
BackgroundVersatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.
Mukherjee, S., Shelar, B., & Krishna, S. (2022) · PubMed · Cited by 36
MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
Andrikopoulou, Α., Shalit, A., Zografos, E., Koutsoukos, K., Korakiti, A.-M., Liontos, M., Dimopoulos, M. A., & Zagouri, F. (2021) · Cancers · doi:10.3390/cancers13164114 · Cited by 29
Microribonucleic acids and gastric cancer
Ma, Y., & Tao, H. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2011.02185.x · Cited by 29
Lee, H.-E., Huh, J., & Kim, H. (2020) · Life · doi:10.3390/life10060095 · Cited by 25
Self-citationClinical significance of microRNA-24 expression in esophageal squamous cell carcinoma
Dong, W., Li, B., Wang, Z., ZHANG, Z., & Wang, J. (2015) · Neoplasma · doi:10.4149/neo_2015_030 · Cited by 24
“in addition, miR-24 appears to inhibit the tumor suppressor p16 [22], reduce the DNA repair ability[23], inhibit cell cycle progression [24], suppress apoptosis [20], and is positively connected with hypoxia [25].”
BackgroundNeault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
The impact of mRNA turnover and translation on age-related muscle loss
Ma, J. F., Hall, D. T., & Gallouzi, I. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.05.004 · Cited by 24
The roles of MTOR and miRNAs in endothelial cell senescence
Khor, E.-S., & Wong, P. (2020) · Biogerontology · doi:10.1007/s10522-020-09876-w · Cited by 24
mir-24 activity propagates stress-induced senescence by down regulating DNA topoisomerase 1
Bu, H., Baraldo, G., Lepperdinger, G., & Jansen‐Dürr, P. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.12.012 · Cited by 26
Hara, T., Jones, M. F., Subramanian, M., Li, X. L., Ou, O. L., Zhu, Y. J., Yang, Y.-A., Wakefield, L. M., Hussain, S. P., Gaedcke, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2284 · Cited by 23
“Recently, we and others have shown that miRNAs can also inhibit gene expression by binding to the coding region or the 5’UTR of target mRNAs [38-41].”
Self-citationStem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
Leal, J. A., Feliciano, A., & LLeonart, M. E. (2011) · Medicinal Research Reviews · doi:10.1002/med.20246 · Cited by 22
Research Progress of Aging-related MicroRNAs
Chen, Z., Li, C., Huang, H., Shi, Y.-L., & Wang, X. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230308111043 · Cited by 21
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition
Hu, Q., & Huang, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108939 · Cited by 26
Fujiwara‐Igarashi, A., Goto‐Koshino, Y., Sato, M., Maeda, S., Igarashi, H., Takahashi, M., Fujino, Y., Ohno, K., & Tsujimoto, H. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.11.004 · Cited by 20
An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells
Barclay, R. A., Khatkar, P., Mensah, G. A., DeMarino, C., Chu, J. S. C., Lepene, B. S., Zhou, W., Gillevet, P. M., Torkzaban, B., Khalili, K., et al. (2019) · Cells · doi:10.3390/cells8080787 · Cited by 22
“In T-cell EVs, some of these miRNAs, such as miR-24 and miR-31, targeted apoptotic proteins, which may enable HIV-1 to promote a pro-cancer environment [67,84].”
BackgroundKitagawa, Y., Brahmachary, M., Tiacci, E., Dalla‐Favera, R., Falini, B., & Basso, K. (2012) · Leukemia · doi:10.1038/leu.2012.149 · Cited by 20
miR clusters target cellular functional complexes by defining their degree of regulatory freedom
Haier, J., Ströse, A., Matuszcak, C., & Hummel, R. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9617-1 · Cited by 19
Soroosh, A., Fang, K., Hoffman, J. M., Law, I. K. M., Videlock, E. J., Lokhandwala, Z. A., Zhao, J. J., Hamidi, S., Padua, D. M., Frey, M. R., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04463-4 · Cited by 18
“Second, while we focused on BCL-2 family proteins, miR-24-3p has also been shown to target mRNAs of other pro-apoptotic proteins such as FAF1 (FASassociated factor 1) and the senescence-associated protein p16 [31, 32].”
BackgroundThe Biology of Classic Hairy Cell Leukemia
Bohn, J., Salcher, S., Pircher, A., Untergasser, G., & Wolf, D. G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157780 · Cited by 17
Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling
Belharazem, D., Grass, A., Paul, C., Vitacolonna, M., Schalke, B. C. G., Rieker, R. J., Körner, D., Jungebluth, P., Simon‐Keller, K., Hohenberger, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15929 · Cited by 17
“Other known regulatory mechanisms of CDKN2A expression, such as methylation [25, 26], and miR-24 [26, 27] have not been studied in TETs.”
BackgroundThe interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer
Balaraman, A. K., Afzal, M., Moglad, E. H. O., Babu, M. A., Priya, G. P., Bansal, P., Rajotiya, S., Kondapavuluri, B. K., Kazmi, I. A., Alzarea, S. I., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10194-2 · Cited by 16
“Various miRNAs, including miR-24 and miR-21, target p16INK4a, reducing its expression and influencing cell proliferation (Lal et al. 2008).”
Shinde, S., Arora, N., & Bhadra, U. (2013) · International Journal of Genomics · doi:10.1155/2013/383024 · Cited by 17
“Distribution of target sites on genes is rarely uniform and these target sites are often found scattered across a region, and range of occurrence is also known to vary in numbers in a gene [27].”
BackgroundEfficiency of the miRNA–mRNA Interaction Prediction Programs
Plotnikova, O., & Skoblov, M. Y. (2018) · Molecular Biology · doi:10.1134/s0026893318020103 · Cited by 16
Jo, H.-R., & Jeong, J. (2022) · Cells · doi:10.3390/cells11030584 · Cited by 19
Comparison of senescence-associated miRNAs in primary skin and lung fibroblasts
Holly, A. C., Grellscheid, S. N., de Walle, P. V., Dolan, D., Pilling, L. C., Daniels, D. J., von Zglinicki, T., Ferrucci, L., Melzer, D. R., & Harries, L. W. (2015) · Biogerontology · doi:10.1007/s10522-015-9560-5 · Cited by 16
Shen, J., Siegel, A. B., Remotti, H. E., Wang, Q., & Santella, R. M. (2016) · Hepatoma Research · doi:10.20517/2394-5079.2015.66 · Cited by 15
“[48] Tumor suppressor gene (p16)[49] and pro-apoptotic protein FAF1[50] can be negatively regulated by miR-24 in cervical carcinoma, prostate, gastric and HeLa cells.”
BackgroundAging‐Related Expression of Twinfilin‐1 Regulates Cholangiocyte Biological Response to Injury
Maroni, L., Pinto, C., Giordano, D. M., Saccomanno, S., Bañales, J. M., Spallacci, D., Albertini, M. C., Orlando, F., Provinciali, M., Milkiewicz, M., et al. (2019) · Hepatology · doi:10.1002/hep.30466 · Cited by 13
Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Hua, X., Li, Y., Pentaparthi, S. R., McGrail, D. J., Zou, R., Guo, L., Shrawat, A., Cirillo, K. M., Li, Q., Bhat, A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-20-0371 · Cited by 16
“Silent and nonsilent mutations in these regions have been shown to be relevant for cancer and other diseases (5, 11, 17).”
BackgroundYoo, J. K., Kim, J., Choi, S., Kim, C., Lee, D. R., Chung, H., & Kim, J. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.030 · Cited by 13
Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.
Feng, Z., Li, Z., Zhu, D., Ling, W., Zheng, L., Pu, L., & Kong, L. (2017) · Europe PMC (PubMed Central) · Cited by 17
Sippl, C., Teping, F., Ketter, R., Braun, L., Tremmel, L. M., Schulz‐Schaeffer, W., Oertel, J., & Urbschat, S. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.07.134 · Cited by 11
Prognostic significance of microRNA miR-24 in cancers: a meta-analysis
Liu, R., Kong, W., Zheng, S., Yu, C.-Y., Yu, Y., Xu, Y., Ye, L., & Shao, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1875662 · Cited by 12
Metadata
- Authors
- Lal, A., Kim, H. H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Srikantan, S., Subrahmanyam, R., Martindale, J. L., Yang, X., Ahmed, F., Navarro, F., Dykxhoorn, D., Lieberman, J., & Gorospe, M.
- Affiliations
- National Institutes of Health (US)
- Harvard University (US)
- Corresponding author
- Lal, Ashish
- Gorospe, Myriam
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-03-26
- Volume
- 3
- Issue
- 3
- Pages
- e1864
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2274865
- OpenAlex
- W2119066197
- Cited by
- 268
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 13 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 14 · 2018: 9 · 2017: 8 · 2016: 8 · 2015: 14 · 2014: 20 · 2013: 22 · 2012: 26
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, miR-24, microRNA, translation repression, translational regulation, replicative senescence, aging, tumor suppressor, 3' untranslated region, cervical cancer, human diploid fibroblasts
- MeSH terms
- Base Sequence, HeLa Cells, Humans, Protein Biosynthesis, Mutagenesis, Site-Directed, DNA Primers, Cyclin-Dependent Kinase Inhibitor p16, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.